HLA-DP polymorphisms affect the clearance rate of type B HBV, regulate the immune selection of viral mutations, influence cirrhosis, and increase the risk of HCC leading to HBV mutations [23]. This evidence concerns the gene HLA-DPB1 and hepatocellular carcinoma.